Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients von Charles‐Schoeman, Christina, Fleischmann, Roy, Mysler, Eduardo, Greenwald, Maria, Ytterberg, Steven R., Koch, Gary G., Bhatt, Deepak L., Wang, Cunshan, Mikuls, Ted R., Chen, All‐shine, Connell, Carol A., Woolcott, John C., Menon, Sujatha, Chen, Yan, Lee, Kristen, Szekanecz, Zoltán

Volltext

Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis von Burmester, Gerd R., Coates, Laura C., Cohen, Stanley B., Tanaka, Yoshiya, Vranic, Ivana, Nagy, Edward, Lazariciu, Irina, Chen, All-shine, Kwok, Kenneth, Fallon, Lara, Kinch, Cassandra

Volltext

Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis von Burmester, Gerd R., Coates, Laura C., Cohen, Stanley B., Tanaka, Yoshiya, Vranic, Ivana, Nagy, Edward, Lazariciu, Irina, Chen, All-shine, Kwok, Kenneth, Fallon, Lara, Kinch, Cassandra

Volltext

Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillanc... von Balanescu, Andra-Rodica, Citera, Gustavo, Pascual-Ramos, Virginia, Bhatt, Deepak L, Connell, Carol A, Gold, David, Chen, All-Shine, Sawyerr, Gosford, Shapiro, Andrea B, Pope, Janet E, Schulze-Koops, Hendrik

Volltext bestellen

LIGHT DELIVERY SYSTEM von HEACOCK GREGORY L, SHINE DAVID B, CHEN JAMES C, BARNARD WILLIAM LOUIS, DAHM JONATHAN S

Volltext bestellen